Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 17, 2024
Staining pattern of specific and cross-reacting Melan-A antibodies: A comparative study on 15,840 samples from 133 human tumor typesShiva Boroojerdi, Sören Weidemann, Anne Menz, et al.
Diagnostics (Basel, Switzerland)|October 28, 2023
Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer TissuesLaura Sophie Tribian, Maximilian Lennartz, Doris Höflmayer, et al.
Human Pathology|March 7, 2025
Estrogen receptor expression in human tumors: A tissue microarray study evaluating more than 18,000 tumors from 149 different entitiesFlorian Viehweger, Justus Gusinde, Nicolai Leege, et al.
The Journal of Pathology|April 4, 2025
A Tc1- and Th1-T-lymphocyte-rich tumor microenvironment is a hallmark of MSI colorectal cancerZhihao Huang, Tim Mandelkow, Nicolaus F Debatin, et al.
Cancer Medicine|March 13, 2026
Pattern and Clinical Significance of CA19-9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 TumorsNina Schraps, Anne Menz, Florian Viehweger, et al.
Cancer Medicine|November 13, 2024
Prevalence and Significance of AGR2 Expression in Human CancerNina Schraps, Jacob Constantin Port, Anne Menz, et al.
The American Journal of Surgical Pathology|April 22, 2024
TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor EntitiesMaximilian Lennartz, Neele Löhr, Doris Höflmayer, et al.
Medical Molecular Morphology|December 29, 2020
Elevated MUC5AC expression is associated with mismatch repair deficiency and proximal tumor location but not with cancer progression in colon cancerSebastian Dwertmann Rico, Doris Höflmayer, Franziska Büscheck, et al.
Prostate Cancer and Prostatic Diseases|November 4, 2025
High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancerNeele Heckmann, Henning Plage, Ronald Simon, et al.
Pageof 8